Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
330 participants
INTERVENTIONAL
2014-06-30
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Comparison of the Effect of Different Oxytocin Administrations on the Blood Loss During Cesarean Delivery
NCT03967171
Cervical Traction and Postpartum Hemorrhage
NCT06179147
Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage
NCT01180192
Comparison Of The Effects Of Carbetocin And Oxytocin In C-Sectıon
NCT05742854
Determination of Blood Loss After CS
NCT04549012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Oxytocin 10IU im was administered after placental delivery
Oxytocin
Oxytocin 10IU Administered intramuscularly.
Study Group
Oxytocin 10IU im was administered after the anterior shoulder could be seen.
Oxytocin
Oxytocin 10IU Administered intramuscularly.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxytocin
Oxytocin 10IU Administered intramuscularly.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancy
* Gestational age \>35 weeks,
* In active labour.
* Expected fetal birth weight 2500-4500 grams.
Exclusion Criteria
* Conversion to abdominal delivery
* Persistent high blood pressure (\>140/90mmHg)
* Placenta Previa
* Ablatio placenta
* Previous C-Section
* Uterine scar
* Postpartum hemorrhage in previous pregnancies.
* Hydramnios
* Maternal infection
* Forceps/Vacuum Assisted deliveries
* Abnormal placentation ( Placenta accreta, increta or percreta)
* Coagulation Defects
* Hemoglobin \< 8g/dl
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Bagcilar Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eser Sefik Ozyurek
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Burak Ozkose, MD
Role: STUDY_CHAIR
Kanuni Sultan Suleyman Teaching and Research Hospital, Istanbul
Dogukan Yildirim, MD
Role: PRINCIPAL_INVESTIGATOR
Kanuni Sultan Suleyman Teaching and Research Hospital, Istanbul
Eser S Ozyurek, MD
Role: STUDY_CHAIR
Bagcilar Training and Research Hospital
Batuhan Ustun, MD
Role: STUDY_CHAIR
Kanuni Sultan Suleyman Teaching and Research Hospital, Istanbul
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kanuni Sultan Suleyman Teaching and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Oguz Orhan E, Dilbaz B, Aksakal SE, Altinbas S, Erkaya S. Prospective randomized trial of oxytocin administration for active management of the third stage of labor. Int J Gynaecol Obstet. 2014 Nov;127(2):175-9. doi: 10.1016/j.ijgo.2014.05.022. Epub 2014 Jul 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kanuni-Bagcilar
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.